nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefaclor—MPO—endothelium—skin cancer	0.00295	0.179	CbGeAlD
Cefaclor—MPO—blood vessel—skin cancer	0.00272	0.165	CbGeAlD
Cefaclor—Paraesthesia—Imiquimod—skin cancer	0.00214	0.00218	CcSEcCtD
Cefaclor—Chills—Bleomycin—skin cancer	0.00214	0.00218	CcSEcCtD
Cefaclor—Cardiac failure congestive—Docetaxel—skin cancer	0.00213	0.00217	CcSEcCtD
Cefaclor—Dyspnoea—Imiquimod—skin cancer	0.00213	0.00216	CcSEcCtD
Cefaclor—Somnolence—Imiquimod—skin cancer	0.00212	0.00216	CcSEcCtD
Cefaclor—Hepatobiliary disease—Temozolomide—skin cancer	0.00212	0.00216	CcSEcCtD
Cefaclor—Erythema multiforme—Dactinomycin—skin cancer	0.00211	0.00214	CcSEcCtD
Cefaclor—Sinusitis—Temozolomide—skin cancer	0.0021	0.00214	CcSEcCtD
Cefaclor—Dyspepsia—Imiquimod—skin cancer	0.0021	0.00214	CcSEcCtD
Cefaclor—Decreased appetite—Imiquimod—skin cancer	0.00208	0.00211	CcSEcCtD
Cefaclor—Infestation NOS—Fluorouracil—skin cancer	0.00207	0.0021	CcSEcCtD
Cefaclor—Infestation—Fluorouracil—skin cancer	0.00207	0.0021	CcSEcCtD
Cefaclor—Hypersensitivity—Vemurafenib—skin cancer	0.00206	0.0021	CcSEcCtD
Cefaclor—Gastrointestinal disorder—Imiquimod—skin cancer	0.00206	0.0021	CcSEcCtD
Cefaclor—Pain—Imiquimod—skin cancer	0.00204	0.00208	CcSEcCtD
Cefaclor—Haemoglobin—Temozolomide—skin cancer	0.00202	0.00206	CcSEcCtD
Cefaclor—Haemorrhage—Temozolomide—skin cancer	0.00201	0.00205	CcSEcCtD
Cefaclor—Hepatitis—Temozolomide—skin cancer	0.00201	0.00205	CcSEcCtD
Cefaclor—Conjunctivitis—Fluorouracil—skin cancer	0.00201	0.00204	CcSEcCtD
Cefaclor—Asthenia—Vemurafenib—skin cancer	0.00201	0.00204	CcSEcCtD
Cefaclor—Hallucination—Temozolomide—skin cancer	0.002	0.00204	CcSEcCtD
Cefaclor—Chills—Dactinomycin—skin cancer	0.002	0.00203	CcSEcCtD
Cefaclor—Urinary tract disorder—Temozolomide—skin cancer	0.00199	0.00202	CcSEcCtD
Cefaclor—Oedema peripheral—Temozolomide—skin cancer	0.00198	0.00202	CcSEcCtD
Cefaclor—Pruritus—Vemurafenib—skin cancer	0.00198	0.00201	CcSEcCtD
Cefaclor—Urethral disorder—Temozolomide—skin cancer	0.00197	0.00201	CcSEcCtD
Cefaclor—Feeling abnormal—Imiquimod—skin cancer	0.00197	0.002	CcSEcCtD
Cefaclor—Gastrointestinal pain—Imiquimod—skin cancer	0.00195	0.00199	CcSEcCtD
Cefaclor—Epistaxis—Fluorouracil—skin cancer	0.00195	0.00198	CcSEcCtD
Cefaclor—Hyponatraemia—Docetaxel—skin cancer	0.00194	0.00198	CcSEcCtD
Cefaclor—Sinusitis—Fluorouracil—skin cancer	0.00194	0.00197	CcSEcCtD
Cefaclor—Agranulocytosis—Fluorouracil—skin cancer	0.00193	0.00196	CcSEcCtD
Cefaclor—Ill-defined disorder—Bleomycin—skin cancer	0.00193	0.00196	CcSEcCtD
Cefaclor—Diarrhoea—Vemurafenib—skin cancer	0.00192	0.00195	CcSEcCtD
Cefaclor—Erythema multiforme—Temozolomide—skin cancer	0.0019	0.00194	CcSEcCtD
Cefaclor—Urticaria—Imiquimod—skin cancer	0.0019	0.00193	CcSEcCtD
Cefaclor—Body temperature increased—Imiquimod—skin cancer	0.00189	0.00192	CcSEcCtD
Cefaclor—Abdominal pain—Imiquimod—skin cancer	0.00189	0.00192	CcSEcCtD
Cefaclor—Malaise—Bleomycin—skin cancer	0.00187	0.00191	CcSEcCtD
Cefaclor—Haemoglobin—Fluorouracil—skin cancer	0.00187	0.0019	CcSEcCtD
Cefaclor—Leukopenia—Bleomycin—skin cancer	0.00186	0.00189	CcSEcCtD
Cefaclor—Rhinitis—Fluorouracil—skin cancer	0.00186	0.00189	CcSEcCtD
Cefaclor—Haemorrhage—Fluorouracil—skin cancer	0.00186	0.00189	CcSEcCtD
Cefaclor—Dizziness—Vemurafenib—skin cancer	0.00185	0.00188	CcSEcCtD
Cefaclor—Immune system disorder—Temozolomide—skin cancer	0.00182	0.00185	CcSEcCtD
Cefaclor—Cough—Bleomycin—skin cancer	0.00181	0.00184	CcSEcCtD
Cefaclor—Chills—Temozolomide—skin cancer	0.00181	0.00184	CcSEcCtD
Cefaclor—Ill-defined disorder—Dactinomycin—skin cancer	0.0018	0.00183	CcSEcCtD
Cefaclor—Vomiting—Vemurafenib—skin cancer	0.00178	0.00181	CcSEcCtD
Cefaclor—Chest pain—Bleomycin—skin cancer	0.00177	0.0018	CcSEcCtD
Cefaclor—Myalgia—Bleomycin—skin cancer	0.00177	0.0018	CcSEcCtD
Cefaclor—Rash—Vemurafenib—skin cancer	0.00177	0.00179	CcSEcCtD
Cefaclor—Dermatitis—Vemurafenib—skin cancer	0.00176	0.00179	CcSEcCtD
Cefaclor—Hypersensitivity—Imiquimod—skin cancer	0.00176	0.00179	CcSEcCtD
Cefaclor—Headache—Vemurafenib—skin cancer	0.00175	0.00178	CcSEcCtD
Cefaclor—Discomfort—Bleomycin—skin cancer	0.00175	0.00178	CcSEcCtD
Cefaclor—Malaise—Dactinomycin—skin cancer	0.00175	0.00178	CcSEcCtD
Cefaclor—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.00174	0.00177	CcSEcCtD
Cefaclor—Leukopenia—Dactinomycin—skin cancer	0.00174	0.00176	CcSEcCtD
Cefaclor—Asthenia—Imiquimod—skin cancer	0.00171	0.00174	CcSEcCtD
Cefaclor—Confusional state—Bleomycin—skin cancer	0.00171	0.00174	CcSEcCtD
Cefaclor—Alanine aminotransferase increased—Docetaxel—skin cancer	0.00171	0.00174	CcSEcCtD
Cefaclor—Oedema—Bleomycin—skin cancer	0.0017	0.00172	CcSEcCtD
Cefaclor—Anaphylactic shock—Bleomycin—skin cancer	0.0017	0.00172	CcSEcCtD
Cefaclor—Back pain—Temozolomide—skin cancer	0.0017	0.00172	CcSEcCtD
Cefaclor—Pruritus—Imiquimod—skin cancer	0.00169	0.00172	CcSEcCtD
Cefaclor—Nausea—Vemurafenib—skin cancer	0.00166	0.00169	CcSEcCtD
Cefaclor—Thrombocytopenia—Bleomycin—skin cancer	0.00166	0.00169	CcSEcCtD
Cefaclor—Myalgia—Dactinomycin—skin cancer	0.00165	0.00168	CcSEcCtD
Cefaclor—Tremor—Temozolomide—skin cancer	0.00164	0.00167	CcSEcCtD
Cefaclor—Diarrhoea—Imiquimod—skin cancer	0.00163	0.00166	CcSEcCtD
Cefaclor—Discomfort—Dactinomycin—skin cancer	0.00163	0.00166	CcSEcCtD
Cefaclor—Ill-defined disorder—Temozolomide—skin cancer	0.00163	0.00165	CcSEcCtD
Cefaclor—Anorexia—Bleomycin—skin cancer	0.00162	0.00164	CcSEcCtD
Cefaclor—Agitation—Temozolomide—skin cancer	0.00161	0.00164	CcSEcCtD
Cefaclor—Angioedema—Temozolomide—skin cancer	0.0016	0.00163	CcSEcCtD
Cefaclor—Pancytopenia—Docetaxel—skin cancer	0.00159	0.00162	CcSEcCtD
Cefaclor—Hypotension—Bleomycin—skin cancer	0.00159	0.00161	CcSEcCtD
Cefaclor—Oedema—Dactinomycin—skin cancer	0.00158	0.00161	CcSEcCtD
Cefaclor—Malaise—Temozolomide—skin cancer	0.00158	0.00161	CcSEcCtD
Cefaclor—Dizziness—Imiquimod—skin cancer	0.00158	0.00161	CcSEcCtD
Cefaclor—Vertigo—Temozolomide—skin cancer	0.00158	0.0016	CcSEcCtD
Cefaclor—Leukopenia—Temozolomide—skin cancer	0.00157	0.0016	CcSEcCtD
Cefaclor—Neutropenia—Docetaxel—skin cancer	0.00156	0.00159	CcSEcCtD
Cefaclor—Palpitations—Temozolomide—skin cancer	0.00155	0.00158	CcSEcCtD
Cefaclor—Thrombocytopenia—Dactinomycin—skin cancer	0.00155	0.00157	CcSEcCtD
Cefaclor—Musculoskeletal discomfort—Bleomycin—skin cancer	0.00155	0.00157	CcSEcCtD
Cefaclor—Cough—Temozolomide—skin cancer	0.00153	0.00156	CcSEcCtD
Cefaclor—Paraesthesia—Bleomycin—skin cancer	0.00152	0.00155	CcSEcCtD
Cefaclor—Convulsion—Temozolomide—skin cancer	0.00152	0.00154	CcSEcCtD
Cefaclor—Vomiting—Imiquimod—skin cancer	0.00152	0.00154	CcSEcCtD
Cefaclor—Dyspnoea—Bleomycin—skin cancer	0.00151	0.00154	CcSEcCtD
Cefaclor—Anorexia—Dactinomycin—skin cancer	0.00151	0.00153	CcSEcCtD
Cefaclor—Rash—Imiquimod—skin cancer	0.00151	0.00153	CcSEcCtD
Cefaclor—Dermatitis—Imiquimod—skin cancer	0.0015	0.00153	CcSEcCtD
Cefaclor—Headache—Imiquimod—skin cancer	0.0015	0.00152	CcSEcCtD
Cefaclor—Arthralgia—Temozolomide—skin cancer	0.00149	0.00152	CcSEcCtD
Cefaclor—Myalgia—Temozolomide—skin cancer	0.00149	0.00152	CcSEcCtD
Cefaclor—Infestation NOS—Docetaxel—skin cancer	0.00149	0.00152	CcSEcCtD
Cefaclor—Infestation—Docetaxel—skin cancer	0.00149	0.00152	CcSEcCtD
Cefaclor—Anxiety—Temozolomide—skin cancer	0.00149	0.00151	CcSEcCtD
Cefaclor—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.00148	0.0015	CcSEcCtD
Cefaclor—Discomfort—Temozolomide—skin cancer	0.00147	0.0015	CcSEcCtD
Cefaclor—Decreased appetite—Bleomycin—skin cancer	0.00147	0.0015	CcSEcCtD
Cefaclor—SLC15A1—epithelium—skin cancer	0.00147	0.0894	CbGeAlD
Cefaclor—Pain—Bleomycin—skin cancer	0.00145	0.00147	CcSEcCtD
Cefaclor—Conjunctivitis—Docetaxel—skin cancer	0.00145	0.00147	CcSEcCtD
Cefaclor—Leukopenia—Fluorouracil—skin cancer	0.00145	0.00147	CcSEcCtD
Cefaclor—Confusional state—Temozolomide—skin cancer	0.00144	0.00147	CcSEcCtD
Cefaclor—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.00144	0.00147	CcSEcCtD
Cefaclor—Anaphylactic shock—Temozolomide—skin cancer	0.00143	0.00145	CcSEcCtD
Cefaclor—Oedema—Temozolomide—skin cancer	0.00143	0.00145	CcSEcCtD
Cefaclor—Nausea—Imiquimod—skin cancer	0.00142	0.00144	CcSEcCtD
Cefaclor—Hepatobiliary disease—Docetaxel—skin cancer	0.00141	0.00143	CcSEcCtD
Cefaclor—Epistaxis—Docetaxel—skin cancer	0.00141	0.00143	CcSEcCtD
Cefaclor—Nervous system disorder—Temozolomide—skin cancer	0.0014	0.00143	CcSEcCtD
Cefaclor—Thrombocytopenia—Temozolomide—skin cancer	0.0014	0.00142	CcSEcCtD
Cefaclor—Convulsion—Fluorouracil—skin cancer	0.0014	0.00142	CcSEcCtD
Cefaclor—Feeling abnormal—Bleomycin—skin cancer	0.0014	0.00142	CcSEcCtD
Cefaclor—MPO—connective tissue—skin cancer	0.0014	0.0847	CbGeAlD
Cefaclor—Agranulocytosis—Docetaxel—skin cancer	0.00139	0.00142	CcSEcCtD
Cefaclor—Hyperhidrosis—Temozolomide—skin cancer	0.00138	0.00141	CcSEcCtD
Cefaclor—Chest pain—Fluorouracil—skin cancer	0.00138	0.0014	CcSEcCtD
Cefaclor—Myalgia—Fluorouracil—skin cancer	0.00138	0.0014	CcSEcCtD
Cefaclor—Decreased appetite—Dactinomycin—skin cancer	0.00138	0.0014	CcSEcCtD
Cefaclor—Anorexia—Temozolomide—skin cancer	0.00136	0.00139	CcSEcCtD
Cefaclor—Discomfort—Fluorouracil—skin cancer	0.00136	0.00138	CcSEcCtD
Cefaclor—Pain—Dactinomycin—skin cancer	0.00135	0.00138	CcSEcCtD
Cefaclor—Urticaria—Bleomycin—skin cancer	0.00135	0.00137	CcSEcCtD
Cefaclor—Haemoglobin—Docetaxel—skin cancer	0.00135	0.00137	CcSEcCtD
Cefaclor—Rhinitis—Docetaxel—skin cancer	0.00134	0.00137	CcSEcCtD
Cefaclor—Body temperature increased—Bleomycin—skin cancer	0.00134	0.00136	CcSEcCtD
Cefaclor—Hepatitis—Docetaxel—skin cancer	0.00134	0.00136	CcSEcCtD
Cefaclor—Haemorrhage—Docetaxel—skin cancer	0.00134	0.00136	CcSEcCtD
Cefaclor—Confusional state—Fluorouracil—skin cancer	0.00133	0.00135	CcSEcCtD
Cefaclor—MPO—epithelium—skin cancer	0.00132	0.0804	CbGeAlD
Cefaclor—Urinary tract disorder—Docetaxel—skin cancer	0.00132	0.00134	CcSEcCtD
Cefaclor—Oedema peripheral—Docetaxel—skin cancer	0.00132	0.00134	CcSEcCtD
Cefaclor—Anaphylactic shock—Fluorouracil—skin cancer	0.00132	0.00134	CcSEcCtD
Cefaclor—Oedema—Fluorouracil—skin cancer	0.00132	0.00134	CcSEcCtD
Cefaclor—Urethral disorder—Docetaxel—skin cancer	0.00131	0.00133	CcSEcCtD
Cefaclor—Feeling abnormal—Dactinomycin—skin cancer	0.0013	0.00133	CcSEcCtD
Cefaclor—Musculoskeletal discomfort—Temozolomide—skin cancer	0.0013	0.00133	CcSEcCtD
Cefaclor—Insomnia—Temozolomide—skin cancer	0.00129	0.00132	CcSEcCtD
Cefaclor—Gastrointestinal pain—Dactinomycin—skin cancer	0.00129	0.00132	CcSEcCtD
Cefaclor—Nervous system disorder—Fluorouracil—skin cancer	0.00129	0.00131	CcSEcCtD
Cefaclor—Thrombocytopenia—Fluorouracil—skin cancer	0.00129	0.00131	CcSEcCtD
Cefaclor—Paraesthesia—Temozolomide—skin cancer	0.00128	0.00131	CcSEcCtD
Cefaclor—SLC15A1—mammalian vulva—skin cancer	0.00128	0.0775	CbGeAlD
Cefaclor—Dyspnoea—Temozolomide—skin cancer	0.00128	0.0013	CcSEcCtD
Cefaclor—Somnolence—Temozolomide—skin cancer	0.00127	0.00129	CcSEcCtD
Cefaclor—Erythema multiforme—Docetaxel—skin cancer	0.00127	0.00129	CcSEcCtD
Cefaclor—MPO—skin of body—skin cancer	0.00126	0.0765	CbGeAlD
Cefaclor—Dyspepsia—Temozolomide—skin cancer	0.00126	0.00128	CcSEcCtD
Cefaclor—Anorexia—Fluorouracil—skin cancer	0.00126	0.00128	CcSEcCtD
Cefaclor—Abdominal pain—Dactinomycin—skin cancer	0.00125	0.00127	CcSEcCtD
Cefaclor—Body temperature increased—Dactinomycin—skin cancer	0.00125	0.00127	CcSEcCtD
Cefaclor—Hypersensitivity—Bleomycin—skin cancer	0.00125	0.00127	CcSEcCtD
Cefaclor—Decreased appetite—Temozolomide—skin cancer	0.00124	0.00126	CcSEcCtD
Cefaclor—Gastrointestinal disorder—Temozolomide—skin cancer	0.00124	0.00126	CcSEcCtD
Cefaclor—Hypotension—Fluorouracil—skin cancer	0.00123	0.00125	CcSEcCtD
Cefaclor—Pain—Temozolomide—skin cancer	0.00122	0.00124	CcSEcCtD
Cefaclor—Constipation—Temozolomide—skin cancer	0.00122	0.00124	CcSEcCtD
Cefaclor—Asthenia—Bleomycin—skin cancer	0.00122	0.00124	CcSEcCtD
Cefaclor—Immune system disorder—Docetaxel—skin cancer	0.00121	0.00123	CcSEcCtD
Cefaclor—Chills—Docetaxel—skin cancer	0.0012	0.00122	CcSEcCtD
Cefaclor—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.0012	0.00122	CcSEcCtD
Cefaclor—Pruritus—Bleomycin—skin cancer	0.0012	0.00122	CcSEcCtD
Cefaclor—Insomnia—Fluorouracil—skin cancer	0.00119	0.00121	CcSEcCtD
Cefaclor—Paraesthesia—Fluorouracil—skin cancer	0.00118	0.0012	CcSEcCtD
Cefaclor—Feeling abnormal—Temozolomide—skin cancer	0.00118	0.0012	CcSEcCtD
Cefaclor—Dyspnoea—Fluorouracil—skin cancer	0.00118	0.0012	CcSEcCtD
Cefaclor—Somnolence—Fluorouracil—skin cancer	0.00117	0.00119	CcSEcCtD
Cefaclor—Gastrointestinal pain—Temozolomide—skin cancer	0.00117	0.00119	CcSEcCtD
Cefaclor—Hypersensitivity—Dactinomycin—skin cancer	0.00117	0.00119	CcSEcCtD
Cefaclor—Dyspepsia—Fluorouracil—skin cancer	0.00116	0.00118	CcSEcCtD
Cefaclor—Decreased appetite—Fluorouracil—skin cancer	0.00115	0.00117	CcSEcCtD
Cefaclor—Gastrointestinal disorder—Fluorouracil—skin cancer	0.00114	0.00116	CcSEcCtD
Cefaclor—Urticaria—Temozolomide—skin cancer	0.00114	0.00116	CcSEcCtD
Cefaclor—Asthenia—Dactinomycin—skin cancer	0.00114	0.00115	CcSEcCtD
Cefaclor—Body temperature increased—Temozolomide—skin cancer	0.00113	0.00115	CcSEcCtD
Cefaclor—Abdominal pain—Temozolomide—skin cancer	0.00113	0.00115	CcSEcCtD
Cefaclor—Back pain—Docetaxel—skin cancer	0.00113	0.00115	CcSEcCtD
Cefaclor—Pain—Fluorouracil—skin cancer	0.00113	0.00115	CcSEcCtD
Cefaclor—Feeling abnormal—Fluorouracil—skin cancer	0.00109	0.0011	CcSEcCtD
Cefaclor—Diarrhoea—Dactinomycin—skin cancer	0.00108	0.0011	CcSEcCtD
Cefaclor—Vomiting—Bleomycin—skin cancer	0.00108	0.0011	CcSEcCtD
Cefaclor—Rash—Bleomycin—skin cancer	0.00107	0.00109	CcSEcCtD
Cefaclor—Dermatitis—Bleomycin—skin cancer	0.00107	0.00109	CcSEcCtD
Cefaclor—Hypersensitivity—Temozolomide—skin cancer	0.00105	0.00107	CcSEcCtD
Cefaclor—Urticaria—Fluorouracil—skin cancer	0.00105	0.00106	CcSEcCtD
Cefaclor—Syncope—Docetaxel—skin cancer	0.00105	0.00106	CcSEcCtD
Cefaclor—Leukopenia—Docetaxel—skin cancer	0.00104	0.00106	CcSEcCtD
Cefaclor—Body temperature increased—Fluorouracil—skin cancer	0.00104	0.00106	CcSEcCtD
Cefaclor—Palpitations—Docetaxel—skin cancer	0.00103	0.00105	CcSEcCtD
Cefaclor—Asthenia—Temozolomide—skin cancer	0.00103	0.00104	CcSEcCtD
Cefaclor—Loss of consciousness—Docetaxel—skin cancer	0.00102	0.00104	CcSEcCtD
Cefaclor—MPO—lymphoid tissue—skin cancer	0.00102	0.0619	CbGeAlD
Cefaclor—Cough—Docetaxel—skin cancer	0.00102	0.00103	CcSEcCtD
Cefaclor—Pruritus—Temozolomide—skin cancer	0.00101	0.00103	CcSEcCtD
Cefaclor—Convulsion—Docetaxel—skin cancer	0.00101	0.00103	CcSEcCtD
Cefaclor—Nausea—Bleomycin—skin cancer	0.00101	0.00102	CcSEcCtD
Cefaclor—Vomiting—Dactinomycin—skin cancer	0.00101	0.00102	CcSEcCtD
Cefaclor—Rash—Dactinomycin—skin cancer	0.000998	0.00101	CcSEcCtD
Cefaclor—Myalgia—Docetaxel—skin cancer	0.000993	0.00101	CcSEcCtD
Cefaclor—Arthralgia—Docetaxel—skin cancer	0.000993	0.00101	CcSEcCtD
Cefaclor—Chest pain—Docetaxel—skin cancer	0.000993	0.00101	CcSEcCtD
Cefaclor—Diarrhoea—Temozolomide—skin cancer	0.000979	0.000995	CcSEcCtD
Cefaclor—Hypersensitivity—Fluorouracil—skin cancer	0.000971	0.000988	CcSEcCtD
Cefaclor—Confusional state—Docetaxel—skin cancer	0.000959	0.000976	CcSEcCtD
Cefaclor—Anaphylactic shock—Docetaxel—skin cancer	0.000952	0.000968	CcSEcCtD
Cefaclor—Oedema—Docetaxel—skin cancer	0.000952	0.000968	CcSEcCtD
Cefaclor—Dizziness—Temozolomide—skin cancer	0.000946	0.000962	CcSEcCtD
Cefaclor—Nausea—Dactinomycin—skin cancer	0.00094	0.000955	CcSEcCtD
Cefaclor—Shock—Docetaxel—skin cancer	0.000936	0.000952	CcSEcCtD
Cefaclor—Nervous system disorder—Docetaxel—skin cancer	0.000933	0.000949	CcSEcCtD
Cefaclor—Pruritus—Fluorouracil—skin cancer	0.000933	0.000948	CcSEcCtD
Cefaclor—Thrombocytopenia—Docetaxel—skin cancer	0.000932	0.000947	CcSEcCtD
Cefaclor—Vomiting—Temozolomide—skin cancer	0.00091	0.000925	CcSEcCtD
Cefaclor—Anorexia—Docetaxel—skin cancer	0.000907	0.000922	CcSEcCtD
Cefaclor—Rash—Temozolomide—skin cancer	0.000902	0.000917	CcSEcCtD
Cefaclor—Diarrhoea—Fluorouracil—skin cancer	0.000902	0.000917	CcSEcCtD
Cefaclor—Dermatitis—Temozolomide—skin cancer	0.000901	0.000916	CcSEcCtD
Cefaclor—Headache—Temozolomide—skin cancer	0.000896	0.000911	CcSEcCtD
Cefaclor—Hypotension—Docetaxel—skin cancer	0.000889	0.000904	CcSEcCtD
Cefaclor—Dizziness—Fluorouracil—skin cancer	0.000872	0.000886	CcSEcCtD
Cefaclor—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000867	0.000881	CcSEcCtD
Cefaclor—Insomnia—Docetaxel—skin cancer	0.000861	0.000875	CcSEcCtD
Cefaclor—Paraesthesia—Docetaxel—skin cancer	0.000854	0.000869	CcSEcCtD
Cefaclor—Nausea—Temozolomide—skin cancer	0.00085	0.000864	CcSEcCtD
Cefaclor—Dyspnoea—Docetaxel—skin cancer	0.000848	0.000863	CcSEcCtD
Cefaclor—Somnolence—Docetaxel—skin cancer	0.000846	0.00086	CcSEcCtD
Cefaclor—Vomiting—Fluorouracil—skin cancer	0.000838	0.000852	CcSEcCtD
Cefaclor—Dyspepsia—Docetaxel—skin cancer	0.000838	0.000852	CcSEcCtD
Cefaclor—Rash—Fluorouracil—skin cancer	0.000831	0.000845	CcSEcCtD
Cefaclor—Dermatitis—Fluorouracil—skin cancer	0.000831	0.000844	CcSEcCtD
Cefaclor—Decreased appetite—Docetaxel—skin cancer	0.000827	0.000841	CcSEcCtD
Cefaclor—Headache—Fluorouracil—skin cancer	0.000826	0.00084	CcSEcCtD
Cefaclor—MPO—head—skin cancer	0.000822	0.0499	CbGeAlD
Cefaclor—Gastrointestinal disorder—Docetaxel—skin cancer	0.000822	0.000835	CcSEcCtD
Cefaclor—Pain—Docetaxel—skin cancer	0.000814	0.000827	CcSEcCtD
Cefaclor—Constipation—Docetaxel—skin cancer	0.000814	0.000827	CcSEcCtD
Cefaclor—Feeling abnormal—Docetaxel—skin cancer	0.000784	0.000797	CcSEcCtD
Cefaclor—Nausea—Fluorouracil—skin cancer	0.000783	0.000796	CcSEcCtD
Cefaclor—Gastrointestinal pain—Docetaxel—skin cancer	0.000778	0.000791	CcSEcCtD
Cefaclor—Abdominal pain—Docetaxel—skin cancer	0.000752	0.000765	CcSEcCtD
Cefaclor—Body temperature increased—Docetaxel—skin cancer	0.000752	0.000765	CcSEcCtD
Cefaclor—Hypersensitivity—Docetaxel—skin cancer	0.000701	0.000713	CcSEcCtD
Cefaclor—SLC15A2—female reproductive system—skin cancer	0.000684	0.0415	CbGeAlD
Cefaclor—Asthenia—Docetaxel—skin cancer	0.000683	0.000694	CcSEcCtD
Cefaclor—Pruritus—Docetaxel—skin cancer	0.000673	0.000685	CcSEcCtD
Cefaclor—Diarrhoea—Docetaxel—skin cancer	0.000651	0.000662	CcSEcCtD
Cefaclor—Dizziness—Docetaxel—skin cancer	0.000629	0.00064	CcSEcCtD
Cefaclor—Vomiting—Docetaxel—skin cancer	0.000605	0.000615	CcSEcCtD
Cefaclor—Rash—Docetaxel—skin cancer	0.0006	0.00061	CcSEcCtD
Cefaclor—Dermatitis—Docetaxel—skin cancer	0.000599	0.000609	CcSEcCtD
Cefaclor—Headache—Docetaxel—skin cancer	0.000596	0.000606	CcSEcCtD
Cefaclor—MPO—lymph node—skin cancer	0.000576	0.0349	CbGeAlD
Cefaclor—SLC15A2—head—skin cancer	0.000571	0.0347	CbGeAlD
Cefaclor—Nausea—Docetaxel—skin cancer	0.000565	0.000575	CcSEcCtD
Cefaclor—SLC15A2—lymph node—skin cancer	0.0004	0.0243	CbGeAlD
